Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05432479 · ClinicalTrials.gov registry record · NA
Study to Evaluate the Efficacy of a Probiotic in Infantile Colic Symptoms Relief
A NA study of Infantile Colic, sponsored by The Archer-Daniels-Midland Company.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 2
- Study locations
NCT05432479: Recruiting NA study of Infantile Colic, sponsored by The Archer-Daniels-Midland Company.
NCT05432479 is a NA study of Infantile Colic that is actively recruiting participants, run by The Archer-Daniels-Midland Company. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05432479, a NA study of Infantile Colic, is actively recruiting participants, sponsored by The Archer-Daniels-Midland Company.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study evaluates the efficacy of single strain probiotic administered in a form of a sachet in the treatment of infant colic in infants 3-12 weeks old.
Primary Outcome
eDiary parent reported cry and fuss time
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Probiotic
Study Locations (2)
Illinois
- Atlantia Food Clinical Trials - Chicago
Maharashtra
- Pulse Multispeciality Hospital, - Pune
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-09-30 |
| Est. Completion | 2026-05 |
| Phase | NA |
What NCT05432479 shows while recruiting
NCT05432479 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Infantile Colic appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05432479 reports a single indexed study location in Illinois, Maharashtra.
Frequently Asked Questions
What is clinical trial NCT05432479 about?
NCT05432479 is a clinical study titled "Study to Evaluate the Efficacy of a Probiotic in Infantile Colic Symptoms Relief". This study evaluates the efficacy of single strain probiotic administered in a form of a sachet in the treatment of infant colic in infants 3-12 weeks old.
What is the current status of trial NCT05432479?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2022-09-30. Estimated completion is 2026-05.
What conditions does trial NCT05432479 study?
This clinical trial studies the following conditions: Infantile Colic.
What interventions are being tested in trial NCT05432479?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Probiotic (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05432479?
This trial is sponsored by The Archer-Daniels-Midland Company, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05432479 being conducted?
This trial has 2 study locations across Illinois, Maharashtra. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05432479's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI